6 Results for "

Dansyl-Tyr-Val-Gly

" in MedChemExpress (MCE) Product Catalog:
Products (6)

6 Results for "Dansyl-Tyr-Val-Gly" in MCE Product Catalog:

Dansyl-Tyr-Val-Gly
Dansyl-Tyr-Val-Gly
0 Images
Cat. No.: HY-138126
CAS No.: 113527-49-4
Target:  

Inhibitory Antibodies

Research Areas:  

Others

Dansyl-Tyr-Val-Gly is a substrate of peptidylglycine monooxygenase (PHM), with a KD of 22 μM for PHM. Dansyl-Tyr-Val-Gly can be used to investigate the catalytic mechanism, kinetics and inactivation characteristics of PHM .
loading...
    loading...
View All Sizes
Dansyl-Tyr-Val-Gly TFA
Dansyl-Tyr-Val-Gly TFA
0 Images
Cat. No.: HY-138126A
CAS No.: 350691-68-8
Target:  

Others

Research Areas:  

Others

Dansyl-Tyr-Val-Gly TFA is a substrate of peptidylglycine monooxygenase (PHM), with a KD of 22 μM for PHM. Dansyl-Tyr-Val-Gly TFA can be used to investigate the catalytic mechanism, kinetics and inactivation characteristics of PHM .
loading...
    loading...
View All Sizes
N-Isovaleroylglycine
N-Isovaleroylglycine
0 Images
Cat. No.: HY-W015464
CAS No.: 16284-60-9
Category:  

Ketones, Aldehydes, Acids Disease markers Metabolic Disease Endocrine diseases Nervous System Disorder Endogenous metabolite Disease Research Fields

Target:  

Endogenous Metabolite Drug Intermediate

N-Isovaleroylglycine is a peptidylglycine α-amidating monooxygenase (PAM) inhibitor with a Ki value of 2.0 mM against human hsPAM. N-Isovaleroylglycine undergoes oxidative cleavage by purified rat PAM to produce fatty acid amide and glyoxylic acid. N-Isovaleroylglycine exerts competitive inhibition by binding to hsPAM, blocking the amidation of dansyl-Tyr-Val-Gly. N-Isovaleroylglycine exhibits lowered urinary abundance in MRSA-infected mice, which qualifies it as a non-invasive biomarker. N-Isovaleroylglycine can be used in studies related to Staphylococcus aureus pneumonia and diabetic foot .
loading...
    loading...
View All Sizes
N-Isovaleroylglycine-d2
N-Isovaleroylglycine-d2
0 Images
Cat. No.: HY-W015464S1
CAS No.: 1219795-09-1
N-Isovaleroylglycine-d2 is the deuterium labeled N-Isovaleroylglycine (HY-W015464). N-Isovaleroylglycine is a peptidylglycine α-amidating monooxygenase (PAM) inhibitor with a Ki value of 2.0 mM against human hsPAM. N-Isovaleroylglycine undergoes oxidative cleavage by purified rat PAM to produce fatty acid amide and glyoxylic acid. N-Isovaleroylglycine exerts competitive inhibition by binding to hsPAM, blocking the amidation of dansyl-Tyr-Val-Gly. N-Isovaleroylglycine exhibits lowered urinary abundance in MRSA-infected mice, which qualifies it as a non-invasive biomarker. N-Isovaleroylglycine can be used in studies related to Staphylococcus aureus pneumonia and diabetic foot .
loading...
    loading...
View All Sizes
N-Isovaleroylglycine (Standard)
N-Isovaleroylglycine (Standard)
0 Images
Cat. No.: HY-W015464R
CAS No.: 16284-60-9
Category:  

Ketones, Aldehydes, Acids Disease markers Endocrine diseases Nervous System Disorder Endogenous metabolite

Target:  

Reference Standards Endogenous Metabolite

N-Isovaleroylglycine (Standard) is the analytical standard of N-Isovaleroylglycine (HY-W015464). This product is intended for research and analytical applications. N-Isovaleroylglycine is a peptidylglycine α-amidating monooxygenase (PAM) inhibitor with a Ki value of 2.0 mM against human hsPAM. N-Isovaleroylglycine undergoes oxidative cleavage by purified rat PAM to produce fatty acid amide and glyoxylic acid. N-Isovaleroylglycine exerts competitive inhibition by binding to hsPAM, blocking the amidation of dansyl-Tyr-Val-Gly. N-Isovaleroylglycine exhibits lowered urinary abundance in MRSA-infected mice, which qualifies it as a non-invasive biomarker. N-Isovaleroylglycine can be used in studies related to Staphylococcus aureus pneumonia and diabetic foot .
loading...
    loading...
View All Sizes
N-Isovalerylglycine-d9
N-Isovalerylglycine-d9
0 Images
Cat. No.: HY-W015464S
CAS No.: 1330037-21-2
N-Isovalerylglycine-d9 is the deuterium labeled N-Isovaleroylglycine (HY-W015464). N-Isovaleroylglycine is a peptidylglycine α-amidating monooxygenase (PAM) inhibitor with a Ki value of 2.0 mM against human hsPAM. N-Isovaleroylglycine undergoes oxidative cleavage by purified rat PAM to produce fatty acid amide and glyoxylic acid. N-Isovaleroylglycine exerts competitive inhibition by binding to hsPAM, blocking the amidation of dansyl-Tyr-Val-Gly. N-Isovaleroylglycine exhibits lowered urinary abundance in MRSA-infected mice, which qualifies it as a non-invasive biomarker. N-Isovaleroylglycine can be used in studies related to Staphylococcus aureus pneumonia and diabetic foot .
loading...
    loading...
View All Sizes
Assay Types